IDYA लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:56):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Stats
आज की मात्रा	107 349
औसत मात्रा	755 112
बाजार मूल्य	2.69B
EPS	$-0.530 ( Q1 \| 2024-05-07 )
अगली कमाई की तारीख	( $-0.560 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-17.78 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0510 (0.14%)

AADI -2.65%

ABCL 1.79%

ABCM 0.04%

ABEO -2.37%

ABIO -1.68%

ABOS 1.64%

ABSI 3.07%

ABUS -2.24%

ABVX -3.53%

ACAD -0.54%

ACER -17.95%

ACET -4.44%

ACGN 1.29%

ACHL -4.15%

ACHV -1.72%

ACIU -0.50%

ACLX -0.09%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.54%

ADPT -0.30%

ADTX -3.47%

ADVM -4.29%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.54%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.25%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.46%

ALLR -3.17%

ALNA 3.16%

ALNY 1.80%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.34%

ALVR -0.58%

ALXN 0.00%

ALXO -10.43%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.50%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.65%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.07%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.86%

ARDS -14.23%

ARDX -0.75%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.19%

ARWR -1.86%

ASLN -4.71%

ASMB -5.19%

ASND -0.91%

ATAI -1.46%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.86%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.32%

BCTX 8.12%

BCTXW -22.52%

BCYC 0.85%

BDRX -5.14%

BDTX -0.85%

BEAM 0.24%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 1.18%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.54%

BMEA -9.60%

BMRN 0.36%

BNOX -2.22%

BNTC -2.11%

BNTX -1.26%

BOLD -7.90%

BOLT -0.18%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.18%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.35%

CADL -0.97%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA -0.63%

CARM 12.16%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.41%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.48%

CELC -3.85%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.86%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -2.79%

CGON -0.29%

CGTX -4.55%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING -3.70%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.24%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -0.91%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.89%

CORT 2.17%

COYA -1.46%

CPRX -0.76%

CRBP -1.89%

CRBU -4.83%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.80%

CRSP 1.03%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -2.94%

CTNM -0.65%

CTXR 0.04%

CUE 3.53%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.01%

CYTO -2.73%

DARE 7.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 32.63%

DNLI -1.92%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -4.14%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 1.49%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.51%

EYPT -0.12%

FATE -8.05%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.60%

FBRX -0.04%

FDMT -4.77%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.63%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.47%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.29%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -1.60%

GLMD -2.15%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.98%

GNTA 3.94%

GOSS -7.81%

GOVX 3.65%

GOVXW -49.04%

GPCR -6.62%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.00%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -0.89%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.83%

HRTX 1.80%

HSTO 0.00%

HUMA 1.15%

HUMAW -0.01%

IBRX -4.26%

ICCC 0.22%

ICPT 0.21%

ICU 17.92%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.52%

IFRX -2.66%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.77%

INAB 0.59%

INBX 0.47%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.56%

INSM -0.88%

INTS -2.75%

INVA 0.22%

INZY 1.14%

IOBT -11.02%

IONS 0.11%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.22%

JAZZ -0.55%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.71%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.79%

KTRA 16.29%

KTTA 8.16%

KTTAW 0.92%

KURA -1.78%

KYMR -2.22%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.93%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.01%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.87%

LPCN -3.16%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.50%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.91%

LYRA 2.83%

MACK 0.10%

MBIO -9.40%

MBRX -1.72%

MCRB 1.12%

MDGL -2.42%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -2.91%

MGTA -7.74%

MGTX -2.68%

MGX -2.68%

MIRM -1.36%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.62%

MNKD -1.05%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.67%

MREO -4.43%

MRKR 2.68%

MRNA -5.04%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.18%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.98%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.27%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.46%

NMTR -42.97%

NOVN -24.84%

NRBO 10.92%

NRIX -0.58%

NRSN -6.16%

NRSNW 0.00%

NRXP -4.14%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.20%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.93%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -2.99%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -1.91%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.20%

OMER -0.90%

OMGA 5.41%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -4.53%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.64%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -1.11%

PEPG 0.48%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.95%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.31%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 2.61%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.84%

QSIAW -3.13%

QTTB -4.54%

QURE -0.45%

RAIN -1.63%

RANI 6.42%

RAPT -2.29%

RARE 1.10%

RCKT -8.09%

REGN -0.66%

RENB -3.11%

REPL -2.82%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.59%

RLMD 0.33%

RLYB -0.34%

RNA -0.42%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.32%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.07%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.52%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.38%

SANA -4.15%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -2.17%

SGTX -2.56%

SIOX 22.63%

SLDB -5.00%

SLGL 4.00%

SLN -4.21%

SLNO -2.71%

SLRX 5.23%

SLS -2.99%

SMMT -2.62%

SNDX 0.77%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.85%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -4.80%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.26%

SWTX 0.72%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.12%

TBPH 0.48%

TCBP 2.73%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.21%

TENX -1.27%

TERN -7.59%

TFFP -3.05%

TGTX -2.71%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.35%

TNYA -8.76%

TPST 2.30%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.94%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -7.38%

UBX -2.12%

UNCY -3.38%

URGN -1.45%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.81%

VERU 0.78%

VERV -3.05%

VIGL 5.11%

VINC 1.62%

VIR 0.43%

VIRI -1.57%

VIRX 2.40%

VKTX -1.34%

VLON -13.04%

VNDA -2.36%

VOR -2.02%

VRCA 0.28%

VRDN -4.23%

VRNA -1.00%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.60%

XBIO 0.93%

XBIT 0.21%

XCUR 3.58%

XENE -2.91%

XERS 2.38%

XFOR 3.71%

XLO 1.58%

XLRN 0.00%

XNCR 0.34%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.48%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-31	Rosen Terry J	Buy	16 200	Stock Option (right to buy)
2024-05-31	Kelley Susan L.	Buy	16 200	Stock Option (right to buy)
2024-05-31	Hampton Malcolm Garret	Buy	16 200	Stock Option (right to buy)
2024-05-31	Stein Jeffrey	Buy	16 200	Stock Option (right to buy)
2024-05-31	Morrison Scott W	Buy	16 200	Stock Option (right to buy)

INSIDER POWER
21.44
Last 100 transactions
Buy: 1 731 485 \| Sell: 1 162 652

सहसंबंध (AI algo v.1.1b): Undervalued: 0.09% $35.60 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.48 (neutral)

छोटा: -0.95 (very strong negative)

Signal:(56.346) Neutral

IDEAYA Biosciences Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
MREO	0.887
CPLP	0.874
CFBK	0.865
RBKB	0.841
AVIR	0.828
BHFAP	0.827
BHFAO	0.819
VSTM	0.817

10 सबसे अधिक नकारात्मक सहसंबंध
BFRI	-0.863
STKS	-0.829
SPCB	-0.822
RMTI	-0.816

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

IDEAYA Biosciences Inc सहसंबंध - मुद्रा/वस्त्र

-0.23
( neutral )

-0.41
( neutral )

0.00
( neutral )

0.22
( neutral )

-0.18
( neutral )

0.57
( weak )

IDEAYA Biosciences Inc वित्तीय

Annual	2023
राजस्व:	$23.39M
सकल लाभ:	$19.38M (82.86 %)
EPS:	$-1.960

FY	2023
राजस्व:	$23.39M
सकल लाभ:	$19.38M (82.86 %)
EPS:	$-1.960

FY	2022
राजस्व:	$50.93M
सकल लाभ:	$48.83M (95.87 %)
EPS:	$-1.320

FY	2021
राजस्व:	$27.94M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.410

Financial Reports:

No articles found.

IDEAYA Biosciences Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

IDEAYA Biosciences Inc

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.